Kohlberg Kravis Roberts & Co. L.P.

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
New York, NY
CIK
0001399770
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 71 3,383,953 BBIO, BV, FSK, APP 13F-HR 2/14/2024 000146393124000006
Q3 2023 73 2,849,240 BBIO, BV, FSK, APP RESTATEMENT 1/22/2024 000146393124000003
Q2 2023 71 3,229,395 APP, BBIO, FSK, BV 13F-HR 8/14/2023 000172554723000244
Q1 2023 82 3,322,438 APP, BBIO, FSK, BV 13F-HR 5/15/2023 000146393123000007
Q4 2022 126 2,963,177 APP, BV, FSK, BBIO 13F-HR 2/14/2023 000146393123000004
Q3 2022 216 4,979,092 APP, FISV, BV, LAUR 13F-HR 11/14/2022 000146393122000011
Q2 2022 264 7,521,335 FISV, APP, BV, FSK 13F-HR 8/12/2022 000146393122000008
Q1 2022 276 11,028,774 APP, FISV, BV, FSK 13F-HR 5/16/2022 000156761922011020
Q4 2021 208 18,227,569 APP, FISV, EDR, BV 13F-HR 2/14/2022 000156761922004143
Q3 2021 185 20,050,165 APP, FISV, BBIO, BV 13F-HR 11/15/2021 000156761921020504
Q2 2021 141 24,656,728 APP, FISV, BBIO, IR 13F-HR 8/16/2021 000156761921015746
Q1 2021 101 19,849,035 FISV, IR, BBIO, ASO 13F-HR 5/17/2021 000156761921010548
Q4 2020 60 19,711,494 FISV, BBIO, IR, ASO 13F-HR 2/16/2021 000156761921004092
Q3 2020 65 17,509,665 FISV, IR, BBIO, BV 13F-HR 11/16/2020 000156761920019910
Q2 2020 67 16,386,208 FISV, IR, BBIO, BV 13F-HR 8/14/2020 000156761920015535
Q1 2020 50 15,675,657 FISV, IR, BBIO, BV 13F-HR 5/15/2020 000156761920010611
Q4 2019 54 20,455,805 FISV, IR, BBIO, BV 13F-HR 2/14/2020 000156761920003955
Q3 2019 52 17,777,800 FISV, IR, BV, BBIO 13F-HR 11/14/2019 000156761919021529
Q2 2019 55 8,117,692 IR, BV, BBIO, PRAH 13F-HR 8/14/2019 000156761919016938
Q1 2019 55 6,572,745 IR, BV, PRAH, KREF 13F-HR 5/15/2019 000156761919011160
Q4 2018 56 5,483,174 IR, PRAH, BV, KREF 13F-HR 2/13/2019 000156761919003744
Q3 2018 59 8,819,944 IR, BV, EYE, PRAH 13F-HR 11/14/2018 000156761918006241
Q2 2018 51 8,783,164 IR, BV, PRAH, EYE 13F-HR 8/14/2018 000156761918000992
Q1 2018 42 8,223,848 IR, PRAH, EYE, KREF 13F-HR 5/15/2018 000114036118023893
Q4 2017 52 10,160,178 IR, EYE, PRAH, KREF 13F-HR 2/14/2018 000114036118008215
Q3 2017 1 73,501 WRD NEW HOLDINGS 2/14/2018 000114036118008207
Q3 2017 52 8,587,011 IR, PRAH, USFD, KREF 13F-HR 11/14/2017 000114036117042773
Q2 2017 1 68,259 WRD NEW HOLDINGS 2/14/2018 000114036118008196
Q2 2017 2 510,857 KREF, VRS NEW HOLDINGS 11/14/2017 000114036117042748
Q2 2017 45 8,248,533 IR, PRAH, USFD, GDDY 13F-HR 8/14/2017 000114036117031949
Q1 2017 1 60 VRS NEW HOLDINGS 11/14/2017 000114036117042731
Q1 2017 1 9,790 NOMD NEW HOLDINGS 6/29/2017 000114036117026686
Q1 2017 49 5,562,435 USFD, PRAH, GDDY, ENGILITY HLDGS INC NEW 13F-HR 5/15/2017 000110465917032805
Q4 2016 1 71 VRS NEW HOLDINGS 11/14/2017 000114036117042723
Q4 2016 53 6,267,982 USFD, PRAH, GDDY, HCA 13F-HR 2/14/2017 000110465917009304
Q3 2016 1 65 VRS NEW HOLDINGS 11/14/2017 000114036117042720
Q3 2016 56 8,056,345 USFD, WBA, PRAH, GDDY 13F-HR 11/14/2016 000110465916156936
Q2 2016 51 9,494,163 WBA, USFD, PRAH, GDDY 13F-HR 8/15/2016 000110465916139802
Q1 2016 53 10,094,057 WBA, PRAH, HCA, ZBH 13F-HR 5/16/2016 000110465916121432
Q4 2015 55 10,275,349 WBA, PRAH, HCA, ZBH RESTATEMENT 4/1/2016 000110465916109348
Q3 2015 69 9,408,496 WBA, PRAH, HCA, ZBH RESTATEMENT 4/1/2016 000110465916109340
Q2 2015 58 11,072,574 WBA, PRAH, HCA, SJM RESTATEMENT 4/1/2016 000110465916109337
Q1 2015 90 9,646,047 WBA, PRAH, HCA, SJM 13F-HR 5/15/2015 000110465915038732
Q4 2014 82 7,661,282 WBA, HCA, PRAH, NLSN 13F-HR 2/17/2015 000110465915011324
Q3 2014 88 3,530,395 HCA, NLSN, WBA, GILEAD SCIENCES INC 13F-HR 11/14/2014 000110465914081036
Q2 2014 78 3,401,065 HCA, NLSN, WBA, RNET 13F-HR 8/14/2014 000110465914061103
Q1 2014 134 5,964,150 HCA, NLSN, MRVL, NXPI RESTATEMENT 8/14/2014 000110465914061093
Q4 2013 126 5,946,266 HCA, NLSN, NXPI, MRVL 13F-HR 2/14/2014 000110465914010629
Additional filings from Kohlberg Kravis Roberts & Co. L.P. that have since been restated